P815: HIGH VALENCY OF IGM-2644, A CD38XCD3 IGM BISPECIFIC T CELL ENGAGER, DISPLACES DARATUMUMAB BINDING AND INDUCES POTENT MULTIPLE MYELOMA CELL KILLING

類似資料

• P1276: DOSE RESPONSE PROFILE OF IGM-2323, A CD20XCD3 IGM BISPECIFIC T CELL ENGAGER, IN TRANSLATIONAL MODELS SUPPORTS PHASE 2 DOSE SELECTION IN NON-HODGKIN’S LYMPHOMA
  著者:: M. K. Leabman, 等
  出版事項: (2022-06-01)
• Structure, Function, and Therapeutic Use of IgM Antibodies
  著者:: Bruce A. Keyt, 等
  出版事項: (2020-10-01)
• 1078 Agonistic CD40 IgM antibodies enhance immune responses beyond that of IgGs
  著者:: Umesh Muchhal, 等
  出版事項: (2023-11-01)
• 1174 Costimulatory IgM T-cell engagers with enhanced and durable cytotoxicity
  著者:: Yue Wang, 等
  出版事項: (2023-11-01)
• Pediatric Selective IgM Immunodeficiency
  著者:: Marc F. Goldstein, 等
  出版事項: (2008-01-01)